TPM
ABBV icon

Triasima Portfolio Management’s AbbVie ABBV Stock Holding History

Triasima Portfolio Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,221
Closed -$2.79M – 138
2025
Q4 		$2.79M Buy
12,221
+131
+1% +$29.8K 0.42% 69
2025
Q3 		$2.8M Buy
+12,090
New +$2.46M 0.42% 75

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Triasima Portfolio Management's ABBV Position: Q1 2026 in Review

Triasima Portfolio Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 12,221 shares — an estimated $2.79M sold.

Triasima Portfolio Management first reported a position in ABBV in Q3 2025 and held it in 2 quarters. The position peaked at $2.8M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Triasima Portfolio Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Triasima Portfolio Management sold 12,221 AbbVie shares in Q1 2026, an estimated $2.79M.
  • Triasima Portfolio Management first reported a position in AbbVie in Q3 2025 and held it in 2 quarters.
  • Triasima Portfolio Management's AbbVie position peaked at $2.8M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Triasima Portfolio Management's 13F filing for Q1 2026, filed 24 Apr 2026.